nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

01.11.2015 | Original Article

Correlation between serum YKL-40 and carotid intima media thickness in type 1 diabetics

verfasst von: Fatemeh Jafary, Seyyed Peyman Khamechi, Hamid Reza Talari, Mohammad Reza Sharif, Hassan Nikoueinejad, Mojtaba Sehhat

Erschienen in: International Journal of Diabetes in Developing Countries | Sonderheft 3/2015

Einloggen, um Zugang zu erhalten

Abstract

It has been suggested that elevated serum level of YKL-40 could be a risk factor as well as early marker of both type 2 and type 1 diabetes mellitus (T1D) and their complications. We investigated the correlation between serum level of YKL-40 and carotid intima media thickness (cIMT) as well as urinary albumin/creatinine ratio (UACR) in type 1 diabetic patients. A total of 49 patients with T1D and 43 healthy controls underwent the assessment of serum level of YKL-40 (by ELISA) and cIMT measurement (by Doppler ultrasonography). Fasting blood and urine samples were also taken to measure the levels of hemoglobin A1C, lipid profile, CBC, serum and urine creatinine, and urine albumin. Serum levels of YKL-40, cIMT, and UACR were significantly higher in diabetic patients compared to those in healthy people (P < 0.001). Serum levels of YKL-40 had a significant correlation with cIMT, and duration of diabetes. We report that YKL-40 may be a good prognostic as well as diagnostic marker of early macrovascular complications in T1D.

Jarvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation. 2004;109(14):1750–5.PubMedCrossRef

Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care. 1993;16(2):434–44.PubMedCrossRef

Kissela BM, Khoury J, Kleindorfer D, Woo D, Schneider A, Alwell K, et al. Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky stroke study. Diabetes Care. 2005;28(2):355–9.PubMedCrossRef

Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. J Cardiovasc Nurs. 2007;22(3):218–53.PubMedCrossRef

Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459–67.PubMedCrossRef

Atabek ME, Kurtoglu S, Pirgon O, Baykara M. Arterial wall thickening and stiffening in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract. 2006;74(1):33–40.PubMedCrossRef

Dalla Pozza R, Bechtold S, Bonfig W, Putzker S, Kozlik-Feldmann R, Netz H, et al. Age of onset of type 1 diabetes in children and carotid intima medial thickness. J Clin Endocrinol Metab. 2007;92(6):2053–7.PubMedCrossRef

Jarvisalo MJ, Putto-Laurila A, Jartti L, Lehtimaki T, Solakivi T, Ronnemaa T, et al. Carotid artery intima-media thickness in children with type 1 diabetes. Diabetes. 2002;51(2):493–8.PubMedCrossRef

Jarvisalo MJ, Jartti L, Nanto-Salonen K, Irjala K, Ronnemaa T, Hartiala JJ, et al. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation. 2001;104(24):2943–7.PubMedCrossRef

10.

Heilman K, Zilmer M, Zilmer K, Lintrop M, Kampus P, Kals J, et al. Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes. Diabetes Res Clin Pract. 2009;84(2):168–73.PubMedCrossRef

11.

Schwab KO, Doerfer J, Krebs A, Krebs K, Schorb E, Hallermann K, et al. Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia. Eur J Pediatr. 2007;166(6):541–8.PubMedCrossRef

12.

Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kajimoto Y, et al. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes. 1994;43(5):634–9.PubMedCrossRef

13.

Peppa-Patrikiou M, Scordili M, Antoniou A, Giannaki M, Dracopoulou M, Dacou-Voutetakis C. Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care. 1998;21(6):1004–7.PubMedCrossRef

14.

Frost D, Beischer W. Determinants of carotid artery wall thickening in young patients with type 1 diabetes mellitus. Diabet Med. 1998;15(10):851–7.PubMedCrossRef

15.

Yokoyama H, Yoshitake E, Otani T, Uchigata Y, Kawagoe M, Kasahara T, et al. Carotid atherosclerosis in young-aged IDDM associated with diabetic retinopathy and diastolic blood pressure. Diabetes Res Clin Pract. 1993;21(2–3):155–9.PubMedCrossRef

16.

Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med. 2003;348(23):2294–303.PubMedCrossRef

17.

Yavuz T, Akcay A, Omeroglu RE, Bundak R, Sukur M. Ultrasonic evaluation of early atherosclerosis in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2002;15(8):1131–6.PubMedCrossRef

18.

Gunczler P, Lanes R, Lopez E, Esaa S, Villarroel O, Revel-Chion R. Cardiac mass and function, carotid artery intima-media thickness and lipoprotein (a) levels in children and adolescents with type 1 diabetes mellitus of short duration. J Pediatr Endocrinol Metab. 2002;15(2):181–6.PubMedCrossRef

19.

Singh TP, Groehn H, Kazmers A. Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol. 2003;41(4):661–5.PubMedCrossRef

20.

Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem. 1993;268(34):25803–10.PubMed

21.

Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res. 2006;55(6):221–7.PubMedCrossRef

22.

Nordenbaek C, Johansen JS, Junker P, Borregaard N, Sorensen O, Price PA. YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. J Infect Dis. 1999;180(5):1722–6.PubMedCrossRef

23.

Kronborg G, Ostergaard C, Weis N, Nielsen H, Obel N, Pedersen SS, et al. Serum level of YKL-40 is elevated in patients with Streptococcus pneumoniae bacteremia and is associated with the outcome of the disease. Scand J Infect Dis. 2002;34(5):323–6.PubMedCrossRef

24.

Boot RG, van Achterberg TA, van Aken BE, Renkema GH, Jacobs MJ, Aerts JM, et al. Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arterioscler Thromb Vasc Biol. 1999;19(3):687–94.PubMedCrossRef

25.

Nishikawa KC, Millis AJ. gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res. 2003;287(1):79–87.PubMedCrossRef

26.

Rathcke CN, Vestergaard H. YKL-40 - an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol. 2009;8:61.PubMedPubMedCentralCrossRef

27.

Kastrup J, Johansen JS, Winkel P, Hansen JF, Hildebrandt P, Jensen GB, et al. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. Eur Heart J. 2009;30(9):1066–72.PubMedCrossRef

28.

Kucur M, Isman FK, Karadag B, Vural VA, Tavsanoglu S. Serum YKL-40 levels in patients with coronary artery disease. Coron Artery Dis. 2007;18(5):391–6.PubMedCrossRef

29.

Rondbjerg AK, Omerovic E, Vestergaard H. YKL-40 levels are independently associated with albuminuria in type 2 diabetes. Cardiovasc Diabetol. 2011;10:54.PubMedPubMedCentralCrossRef

30.

Rathcke CN, Raymond I, Kistorp C, Hildebrandt P, Faber J, Vestergaard H. Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population. Int J Cardiol. 2010;143(1):35–42.PubMedCrossRef

31.

Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care. 2009;32(2):323–8.PubMedPubMedCentralCrossRef

32.

Rathcke CN, Johansen JS, Vestergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res. 2006;55(2):53–9.PubMedCrossRef

33.

Sakamoto F, Katakami N, Kaneto H, Yasuda T, Takahara M, Miyashita K, et al. Association of serum YKL-40 levels with urinary albumin excretion rate in young Japanese patients with type 1 diabetes mellitus. Endocr J. 2013;60(1):73–9.PubMedCrossRef

34.

Malinda KM, Ponce L, Kleinman HK, Shackelton LM, Millis AJ. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res. 1999;250(1):168–73.PubMedCrossRef

35.

Shackelton LM, Mann DM, Millis AJ. Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem. 1995;270(22):13076–83.PubMedCrossRef

36.

Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond Engl 1979). 2005;109(2):143–59.CrossRef

37.

Yasuda T, Kaneto H, Katakami N, Kuroda A, Matsuoka TA, Yamasaki Y, et al. YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients. Diabetes Res Clin Pract. 2011;91(2):e50–2.PubMedCrossRef

38.

Vigili de Kreutzenberg S, Tiengo A, Avogaro A. Cerebrovascular disease in diabetes mellitus: the role of carotid intima-media thickness. Nutr Metab Cardiovasc Dis. 2009;19(9):667–73.PubMedCrossRef

39.

Krebs A, Schmidt-Trucksass A, Wagner J, Krebs K, Doerfer J, Schwab KO. Adult-like but regressive increase of intima-media thickness and roughness in a child with type 1 diabetes. Pediatr Diabetes. 2005;6(3):161–4.PubMedCrossRef

40.

Harrington J, Pena AS, Gent R, Hirte C, Couper J. Aortic intima media thickness is an early marker of atherosclerosis in children with type 1 diabetes mellitus. J Pediatr. 2010;156(2):237–41.PubMedCrossRef

41.

Reinehr T, Kiess W, de Sousa G, Stoffel-Wagner B, Wunsch R. Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism. 2006;55(1):113–8.PubMedCrossRef

Titel: Correlation between serum YKL-40 and carotid intima media thickness in type 1 diabetics
verfasst von: Fatemeh Jafary
Seyyed Peyman Khamechi
Hamid Reza Talari
Mohammad Reza Sharif
Hassan Nikoueinejad
Mojtaba Sehhat
Publikationsdatum: 01.11.2015
Verlag: Springer India
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe Sonderheft 3/2015
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-015-0363-7

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Correlation between serum YKL-40 and carotid intima media thickness in type 1 diabetics

Abstract

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 3/2015

The eye and the kidney: twin targets in diabetes

Correlations among the components of human somatotype and some anthropological parameters in female patients with type 2 diabetes mellitus

Double-blind randomized placebo-controlled trial to compare the effects of gabapentin, pregabalin and tramadol + acetaminophen combination in improvement of pain in patients with painful diabetic neuropathy

TyG index and insulin resistance in beta-thalassemia

Decreased blood levels of glyoxalase I and diabetic complications

Analysis of DNA damage, plasma lipid peroxidation, and antioxidant status in type 2 diabetes mellitus patients among a south Indian population